Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center

Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial

Official title:

VICC Adolescent and Young Adult Oncology Review

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00670605
• Other study ID #: CDR0000584244
• Secondary ID: P30CA068485VU-VI
• Status: Terminated
• Phase: N/A
• First received: May 1, 2008
• Last updated: March 23, 2011
• Start date: June 2007

Study information

• Verified date: March 2011
• Source: Vanderbilt University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

RATIONALE: Gathering information about the number of young patients with cancer and the outcome of these patients may help doctors learn more about cancer.

PURPOSE: This research study is looking at the medical records of young patients undergoing cancer treatment at the Vanderbilt-Ingram Cancer Center to determine how often cancer occurs and the outcome of these patients.

Description:

OBJECTIVES:

• To determine the number of patients between 15 and 30 years old who are treated for newly diagnosed cancer at the Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and in the state of Tennessee between 1990 and 2005.

• To determine the outcomes of these patients.

• To determine the number of these patients enrolled on clinical trials at VICC.

• To compare the outcomes of these patients when treated on a trial versus not treated on a trial provided they have the same disease.

• To compare the number of these patients who are treated on a clinical trial when they are first seen at Vanderbilt Children's Hospital vs Vanderbilt University Hospital.

• To determine referral patterns of these patients to VICC.

• To compare the outcomes of these patients who are treated at VICC vs middle Tennessee vs the state of Tennessee vs the entire nation.

• To determine the reason for not enrolling on a clinical trial.

OUTLINE: Cancer cases taken from the Vanderbilt-Ingram Cancer Center (VICC) Registry and the Tennessee Cancer Registry are examined for number and types of cancer, mortality rates broken down by county and health department region, electronic medical records, and treatment outcomes. Data is analyzed for comparison of number of new cancer patients, mortality rates, and referral patterns at VICC versus number of new cancer patients in the region, state, and country.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 0
• Est. primary completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 15 Years to 30 Years

Eligibility

DISEASE CHARACTERISTICS:

• Diagnosis of cancer

• Newly diagnosed disease from 1990 to 2005

• 15 to 30 years old at the time of cancer diagnosis

• Must live in the state of Tennessee

PATIENT CHARACTERISTICS:

• Not specified

PRIOR CONCURRENT THERAPY:

• Not specified

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Unspecified Adult Solid Tumor, Protocol Specific
• Unspecified Childhood Solid Tumor, Protocol Specific

Intervention

Other:
• medical chart review

• study of socioeconomic and demographic variables

Locations

Country	Name	City	State
United States	Vanderbilt-Ingram Cancer Center	Nashville	Tennessee
United States	Vanderbilt-Ingram Cancer Center - Cool Springs	Nashville	Tennessee
United States	Vanderbilt-Ingram Cancer Center at Franklin	Nashville	Tennessee

Sponsors (2)

Lead Sponsor	Collaborator
Vanderbilt University	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients with newly diagnosed cancer from 1990 to 2005 and treated at Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and the state of Tennessee			No
Primary	Comparison of outcomes			No
Primary	Number of patients enrolled in clinical trials at VICC			No
Primary	Outcomes of patients treated on a trial vs those not treated with the same disease			No
Primary	Comparison of number of patients treated at Vanderbilt Children's Hospital vs Vanderbilt University Hospital			No
Primary	Referral patterns			No
Primary	Reason for not enrolling on a clinical trial			No